从诊断到管理,形额头狭窄症的临床挑战
Nahoko Kato1, Hiroyuki Watanabe2, Patricia A Pellikka3
1Department of Cardiology, Tokyo Bay Urayasu/Ichikawa Medical Center, Urayasu, Japan; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Journal of cardiology
|June 30, 2025
概括
与状环状化 (MAC) 相关的状缩 (MS) 在老年人群中正在增加. 本综述涵盖了其在诊断,预后和治疗方面的挑战,特别是与共存的大动脉狭窄症.
科学领域:
- 心脏病学 心脏病学
- 膜心脏疾病 膜心脏疾病
- 老年心脏病学 老年心脏病学
背景情况:
- 性额头缩症 (MS) 的患病率正在增加,特别是在老年人群中,通常与额头环状化 (MAC) 相关.
- 严重的MAC阻碍了透静放松,并可以扩展到额叶叶片,导致MS. 大动脉狭窄是MAC患者性MS的重要危险因素.
- 透导管大动脉植入突出了与性MS相关的挑战,使其与性MS区别开来.
研究的目的:
- 审查性MS的病理生理学,诊断,预后和治疗.
- 突出性多发性硬化症带来的临床挑战,特别是在患有并发症的老年患者中.
- 在共存的大动脉狭窄和手术干预的局限性背景下讨论管理性MS的复杂性.
主要方法:
- 文献综述整合了最新的见解.
- 对风湿性MS的诊断和严重程度评估差异的分析.
- 讨论联合主动脉和 mitra 狭窄的血液动力学评估的复杂性.
主要成果:
- 性MS的诊断和评估不同于类风湿性MS.
- 同时存在的大动脉狭窄症使血液动力学评估复杂化.
- 患有并发症的老年患者的预后是复杂的,受一般状况的影响.
结论:
- 严重的MAC带来了外科手术的挑战,增加了对米特拉置换的风险.
- 高风险患者的高外科期死亡率有利于医疗治疗或更少的侵入性干预.
- 了解性MS病理生理学,诊断和预后对于最佳管理至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28
Mitral Stenosis IV: Nursing Management
49
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
49
Mitral Stenosis II: Clinical features and Diagnostic Tests
39
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
39
Mitral Stenosis I: Introduction
48
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
48
Mitral Valve Prolapse II: Assessment and Management
45
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
45
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34


